| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Interest expense | 0 | - | - | - |
| Other financing costs | 0 | - | - | - |
| Change in fair value of convertible notes | 0 | - | - | - |
| Change in fair value of warrants liability | 0 | -16 | -16 | -192 |
| Other financing costs | - | 298 | - | - |
| Change in fair value of convertible notes | - | 0 | - | - |
| Total other income (expense), net | 107 | -246 | 53 | -22 |
| Loss before provision for income taxes | -3,472 | -2,002 | -3,769 | -4,478 |
| Provision for income taxes | 0 | 0 | 3 | - |
| Net loss | -3,472 | -2,002 | -3,772 | -4,478 |
| Earnings per share, diluted | - | -0.18 | -0.44 | -1.1 |
| Weighted average number of shares outstanding, diluted | - | 11,329,517 | 8,617,932 | 4,086,871 |
| Net loss per share of common stock, basic and diluted (in dollars per share) | -0.13 | -0.18 | -0.44 | -1.1 |
| Weighted-average shares outstanding, basic and diluted (in shares) | 26,393,400 | 11,329,517 | 8,617,932 | 4,086,871 |
SeaStar Medical Holding Corp (ICU)
SeaStar Medical Holding Corp (ICU)